Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PVLA

Palvella Therapeutics Inc

May 29 • 04:00PM ET

118.46

+2.60 2.24 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR MANE ORKA RYTM KRYS NUVL BMRN INCY AXSM NBIX

| Held by: VTI XBI IWM VXF IWO VTWO VHT VFMO IWC LFSC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.17	Insider Own	29.46%	Shs Outstand	15.74M	Perf Week	2.19%
Market Cap	1.70B	Forward P/E	-	EPS next Y	-6.43	Insider Trans	-0.45%	Shs Float	10.12M	Perf Month	-3.25%
Enterprise Value	1.46B	PEG	-	EPS next Q	-1.16	Inst Own	83.59%	Short Float	21.22%	Perf Quarter	-12.26%
Income	-49.30M	P/S	-	EPS this Y	-49.62%	Inst Trans	33.14%	Short Ratio	8.79	Perf Half Y	24.87%
Sales	0.00M	P/B	8.03	EPS next Y	-15.88%	ROA	-28.73%	Short Interest	2.15M	Perf YTD	13.17%
Book/sh	14.76	P/C	6.49	EPS next 5Y	16.23%	ROE	-34.25%	52W High	151.18 -21.64%	Perf Year	378.05%
Cash/sh	18.26	P/FCF	-	EPS past 3/5Y	53.08% 41.62%	ROIC	-106.76%	52W Low	20.20 486.44%	Perf 3Y	97.43%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	3.42% 5.89%	Perf 5Y	-56.95%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	66.94%	Oper. Margin	-	ATR (14)	6.52	Perf 10Y	-19.08%
Dividend Ex-Date	-	Quick Ratio	5.20	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	49.31	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	28.88	EPS Q/Q	-62.12%	SMA20	-0.38%	Beta	-0.14	Target Price	229.00
Payout	-	Debt/Eq	0.08	Sales Q/Q	-	SMA50	-2.51%	Rel Volume	0.64	Prev Close	115.86
Employees	29	LT Debt/Eq	0.08	Earnings	May 07 BMO	SMA200	26.61%	Avg Volume	244.25K	Price	118.46
IPO	Jan 02, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-28.34% -	Trades		Volume	155,621	Change	2.24%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)